Optimizing Use of Botulinum Toxin Type A for Pediatric Upper Limb Spasticity: Transforming Science Into Clinical Success

Target Audience

This activity has been designed to address the educational needs of neurologists, physical medicine and rehabilitation physicians (also known as physiatrists), developmental pediatricians, and orthopedic surgeons. It may also be of benefit to other healthcare providers who are involved in the management of spasticity, including pediatric nurse practitioners and PAs.

Statement of Need/Program Overview

This interactive enduring activity will cover the management of pediatric patients with upper limb spasticity (ULS).

Learning Objectives

Upon proper completion of this activity, participants should be better able to:

Evaluate available BoNT-As, including their mechanisms of action, indications, and preparation, as well as their dosing, efficacy, and safety, in pediatric ULS.
Identify the anatomy and pathophysiology of musculature associated with pediatric ULS in which BoNT-As have proven effective in reducing symptoms.
Describe current methods for ensuring accurate delivery of BoNT-As to the appropriate target muscles for pediatric ULS.